Mechanical Thrombectomy Devices Market Size is anticipated to witness significant growth from 2022 to 2028. This can be reasoned to an increase in the geriatric population and acceleration in the rate of cardiovascular diseases worldwide. Various factors like hectic schedules, physical inactivity, and unhealthy diet along with harmful intake of alcohol and use of tobacco will also influence the market progression.
Mechanical thrombectomy is a minimally invasive procedure to remove blood clots from veins and arteries which can cause intrusion in the normal flow of blood leading to life-threatening conditions like strokes. The procedure uses various techniques like stent-retrieval, catheter-based therapies to unclog arteries.
The rise in the use of clot retrievers and stents to treat strokes and an upsurge in the number of vascular diseases is anticipated to drive the use of thrombectomy in surgical centers and hospitals. Additionally, the rising investment in the research and development activities to bring in top-notch thrombectomy devices by manufacturers will also propel the growth of the global mechanical thrombectomy device market.
Based on end-user, mechanical thrombectomy devices market are being widely used across hospitals for the treatment of acute ischemic stroke patients with large artery diseases using stent retrievers. The constant technological developments for minimally invasive surgeries, use of new thrombectomy devices, endovascular thrombectomy with catheters, and stent retrievers, interventional therapy have emerged as the standard treatment for chronic diseases. Due to the non-invasive treatment technology, the patient can be treated within 24 hours in certain cases making it a more highly effective method for removing clots. The increase in number of hospitals across the globe will also create a positive impetus on the overall market growth in the coming years.
The global mechanical thrombectomy devices market will observe considerable growth in North America, through 2028. This is owing to the ongoing technological advancements, cost-effective treatment, increase in the geriatric population, and rising number of patients suffering from neurological and cardiovascular diseases in the region. According to the National Institute of Health, heart ailments like strokes are the most common reason for fatalities in the United States. The increase in adoption of mechanical thrombectomy treatments along with medical reimbursement services from various central governments will propel the growth of the market segment in this region.
The prominent players operating in mechanical thrombectomy devices market are Stryker, Boston Scientific, Johnson & Johnson, Argon Medical devices, Edward Lifesciences Corporation, and others.
These market vendors are going nine yards for introducing novel innovations in the space and engaging in organic marketing strategies like mergers and acquisitions and partnerships to fortify their positions in the overall market space.
The onset of the COVID-19 pandemic has led to a rise in patients suffering from chronic diseases. The effects of coronavirus on the health of patients have increased cases of respiratory failures resulting in deaths. In the beginning of the pandemic, a significant decline in the use of mechanical thrombectomy was observed worldwide. Besides, postponement in treatments using mechanical thrombectomy due to infection control measures has as well negatively impacted the market prospects.
Market, By Type
Market, By Application
Market, By End-user
The above information is provided for the following regions and countries: